1. Home
  2. FBGL vs GNPX Comparison

FBGL vs GNPX Comparison

Compare FBGL & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBGL
  • GNPX
  • Stock Information
  • Founded
  • FBGL 1996
  • GNPX 2009
  • Country
  • FBGL Singapore
  • GNPX United States
  • Employees
  • FBGL N/A
  • GNPX N/A
  • Industry
  • FBGL Miscellaneous manufacturing industries
  • GNPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FBGL Consumer Discretionary
  • GNPX Health Care
  • Exchange
  • FBGL Nasdaq
  • GNPX Nasdaq
  • Market Cap
  • FBGL 8.1M
  • GNPX 7.0M
  • IPO Year
  • FBGL 2025
  • GNPX 2018
  • Fundamental
  • Price
  • FBGL $0.62
  • GNPX $0.24
  • Analyst Decision
  • FBGL
  • GNPX Strong Buy
  • Analyst Count
  • FBGL 0
  • GNPX 1
  • Target Price
  • FBGL N/A
  • GNPX $10.00
  • AVG Volume (30 Days)
  • FBGL 360.1K
  • GNPX 2.8M
  • Earning Date
  • FBGL 01-01-0001
  • GNPX 05-12-2025
  • Dividend Yield
  • FBGL N/A
  • GNPX N/A
  • EPS Growth
  • FBGL N/A
  • GNPX N/A
  • EPS
  • FBGL 0.04
  • GNPX N/A
  • Revenue
  • FBGL $15,607,369.00
  • GNPX N/A
  • Revenue This Year
  • FBGL N/A
  • GNPX N/A
  • Revenue Next Year
  • FBGL N/A
  • GNPX N/A
  • P/E Ratio
  • FBGL $18.50
  • GNPX N/A
  • Revenue Growth
  • FBGL 25.78
  • GNPX N/A
  • 52 Week Low
  • FBGL $0.44
  • GNPX $0.22
  • 52 Week High
  • FBGL $5.45
  • GNPX $4.09
  • Technical
  • Relative Strength Index (RSI)
  • FBGL N/A
  • GNPX 40.63
  • Support Level
  • FBGL N/A
  • GNPX $0.22
  • Resistance Level
  • FBGL N/A
  • GNPX $0.36
  • Average True Range (ATR)
  • FBGL 0.00
  • GNPX 0.03
  • MACD
  • FBGL 0.00
  • GNPX -0.00
  • Stochastic Oscillator
  • FBGL 0.00
  • GNPX 14.93

About FBGL FBS Global Limited Ordinary Shares

FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial and industrial building projects. As a green contractor focused on environmentally sound practices, It aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, lead lining, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts, sales of construction materials, and rendering of services.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: